Manufacturers Life Insurance Company, The Cytek Biosciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 46,740 shares of CTKB stock, worth $306,147. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,740
Previous 64,003
26.97%
Holding current value
$306,147
Previous $357,000
27.73%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CTKB
# of Institutions
134Shares Held
71.7MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$77.1 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$62.2 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$43.6 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$27.3 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $882M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...